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1. Introduction 
Thyroid hormones (TH) have major well-known actions on the growth and development of 
the maturing tissues including mammalian brain via activation of specific nuclear receptors 
leading to gene expression and subsequent target protein synthesis. Deficiency of THs has 
serious issues on the development on all types of tissues including brain leading to severe 
thyroid disorders and as a result imposes overall metabolic malfunctioning of all system 
organs. Endemic goiter was probably first described with cretinism by Paracelsus (1493 -1541) 
and by other physicians of the Alps and Central Europe. However, the relationship between 
cretinism and involvement of thyroid gland was lacking over centuries. Thyroid gland was 
literally described by Wharton in 1656. Since then the progress of research on thyroid gland 
gained attention particularly for its most observed pleiotypic action in number of species from 
aquatic animals to humans. Developments of new scientific technologies and the progress in 
the area of molecular biology from time to time are continually changing our concepts of the 
regulation of the functions of THs at the subcellular level [1,2]. 
Immunocytochemical localization studies revealed that TH receptors (TR) in adult 
vertebrates are highly concentrated within choroids plexus, dentate gyrus, hippocampus, 
amygdaloid complex, pyriform cortex, granular layer of cerebellum, mammillary bodies and 
medial geniculate bodies. Although specific nuclear receptors for THs in adult brain have 
been identified, their functions are unclear about target gene expression. 
Imunohistochemical mapping further documented that locus coeruleus norepinephrine 
stimulates active conversion of L-tetraiodothyronine (L-T4) to L-triiodothyronine (L-T3). A 
morphologic linking between central thyronergic and noradrenergic systems has been 
established. This changes in TH ontogeny gradually started drawing attention that possible 
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TH action in mature brain switches its role which may be different from its classical action 
mediated through nuclear receptors. As the brain approaches adulthood, nuclear levels of 
iodothyronines decline gradually reaching a plateau and maintain it, and the TH levels 
increase within nerve terminals of adult vertebrates [1]. In particular, it showed decrease in 
nuclear L-T3 receptor binding in adult brain compared to developing brain. These switching 
differences in TH ontogeny between developing and adult vertebrate brain has gradually 
interested investigators to search for new functional role and mechanism of action of TH. 
Nevertheless, the action of THs remained limitedly judged in mature mammalian central 
nervous system (CNS) [3,4].  
Recent research highlights about the nonconventional nongenomic action of THs and its 
metabolites. Adult mammalian CNS is of specific interest. Clinical observations specifically 
have shown that the adult-onset thyroid disorders lead to several neuropsychological 
diseases including but not limited to anxiety, depression, mood disorders etc. in humans. 
These complications can be improved with appropriate adjustment of circulatory THs [5-8]. 
However, the defined mechanism to explain this is inadequate. The involvement of TH 
nuclear receptors in ameliorating these neuropsychiatric dysfunctions in mature CNS is 
controversial. Current knowledge about the TH-responsive gene expression in adult 
mammalian CNS is largely unavailable except some few discrete reports with differential 
effects in certain brain areas. Indication of new rapid nongenomic effects of THs and its 
metabolites, within seconds to minutes, poses special significance.  
The interest about the action of TH in brain originated because like the classical 
neurotransmitters, catecholamines, THs are also derived from the amino acid, tyrosine. 
Tyrosine is decarboxylased by specific aromatic amino acid decarboxylase to produce 
catecholamines. There are possibilities that THs can also undergo decarboxylation and form 
biogenic amine-like neuroactive compounds, such as thyronamines or iodothyronamines as 
hypothesized. However recent experiment challenges this initial hypothesis since aromatic 
amino acid decarboxylase failed to produce this and thus presence of TH specific 
decarboxylase is speculated [9]. For example, L-T4 and L-T3 can be decarboxylated to 
produce L-T4-amine and L-T3-amine respectively (Figure 1). L-T3-amine can further be 
deiodinated to form L-T2-amine and then further deiodination can generate L-T1-amine. 
Important deaminated metabolites of L-T4 and L-T3 are tetraiodothyroacetic acid (TETRAC) 
and triiodothyroacetic acid (TRIAC) respectively [9,10]. Thyronamines may have 
neurotransmitter-like actions. However, no evidence is present to-date to identify 
physiologic formation of thyronamines that describe their physiologic functions, except one 
new report which identified 3-iodo-thyronamine in adult brain including other tissue 
homogenates in sub-picomolar concentrations [10]. Few pharmacologic actions for these 
synthetically prepared iodothyronamines are known in other tissues. This theory of action 
of thyroid hormones could be like classical neurotransmission led to search for the 
nongenomic mechanism of action of THs.  
Thus, besides the genomic concepts, a parallel idea of nongenomic of TH action was 
emerging with demonstration of direct plasma membrane-TH interaction and expression of 
some hormonal effects in a variety of cells. These studies include activation on Ca2+-ATPase  
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Figure 1. Thyroid hormones and their deaminated and decarboxylated products of interest. 
in red blood cells, acetylcholinesterase in neuronal plasma membrane, inhibition of 
synaptosomal membrane Na+-K+-ATPase (NKA), rapid action of L-T3 on synaptosomal Ca2+-
influx, identification of specific L-T3-binding sites in rat thymocyte membrane, 
synaptosomal membrane, depolarization of actin filaments in cultured astrocytes by TH, 
and changes in second messengers and their corresponding regulatory systems following 
TH treatment [1,11,12].  
Selective uptakes of THs have also been documented within the nerve terminals. 
Intravenous administration of [125I]-L-T4 in rats followed by thaw mount autoradiography 
has described selective distribution of L-T4 in specific adult rat brain areas particularly 
within the nerve terminals. Within the nerve terminal this was concentrated as L-T3 [10]. 
Other reports about the transportation of TH in adult brain also indicated role of 
transthyretin as a major serum binding protein for TH required for its transportation in 
cerebrospinal fluids and ultimately enable crossing of TH of the blood brain barrier 
directing to the brain. A role of monocarboxylate anion transporter protein-8 (MCT-8) also 
has been found to play a major role in TH transportation across the plasma membrane [10]. 
Three important enzymes called monodeiodinase are involved in TH metabolism. These are 
5’-deiodinase type I (D-I), 5’-deiodinase type II (D-II) and 5’-deiodinase type III (D-III). D-I 
and D-II catalyzes conversion of the L-T4 to L-T3. D-I is the major deiodinating enzyme in 
the peripheral tissues. In brain D-II is predominantly localized in glial cells, astrocytes, and 
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in the tanycytes lining the lower part of the third ventricles. D-III catalyzes the conversion of 
L-T3 to L-T2. Concentration of L-T3 within the nervous system has been attributed to the 
brain D-II which has major functions in regulating the overall neuronal homeostasis for TH. 
Expression of D-II in nervous tissue is implicated in the neuronal uptake of the circulatory 
L-T4 and its conversion to L-T3 followed by its supply to the neuronal targets. Expression of 
D-II is an important protective mechanism against hypothyroidism. This prevalence of TH 
homeostasis is a preventive measure and thought to be neuroprotective [1,13-16].  
Interest also materializes to explore further the nongenomic mechanism of action of THs in 
adult mammalian CNS. In this context TH-mediated signal transduction pathways are also 
being investigated. Particularly the regulation of the activation of the second messenger 
systems and subsequent protein phosphorylation are of much awareness. Understanding of 
the mechanism of action of TH in adult mammalian brain has key implications in the higher 
mental functions, learning and memory, and in the regulation of several neuropsychiatric 
disorders developed during adult-onset thyroid dysfunctions in humans.  
2. Aim of the article 
The major goal of this article is to search, discuss and review the nongenomic rapid actions 
of THs in mature mammalian CNS. This article aims to begin with observations describing 
subcellular distribution, and concentrations of THs within the brain and its biochemical and 
physiologic consequences, specific binding of THs onto the neuronal plasma membrane to 
examine for specific plasma membrane receptors of THs and correlate the receptor-binding 
followed by a specific cellular function. Next, the molecular basis of the TH and plasma 
membrane receptor interaction-mediated signals are evaluated via possible activation of G-
protein signaling pathway, second messenger systems, and subsequent target protein 
phosphorylation.  
3. Hypothesis  
Thyroid hormones exercise a nongenomic action on the adult mammalian brain possibly by 
binding to neuronal membrane receptors followed by activation of second messenger 
cascade systems leading to substrate level protein phosphorylation and dephosphorylation 
by protein kinases and protein phosphatases (Figure 2).  
4. Experimental tissue of interest 
Author’s experiments and results reported in this manuscript are obtained from the purified 
synaptosomes prepared from young adult rat brain cerebral cortex. Synaptosomes are 
subcellular nucleus-free preparation purified through density gradient centrifugation [17]. 
The question may arise why synaptosome? Synapses are the ultimate routes of 
communications in neurons where electrical impulses are normally translated to chemical 
signals from one neuron to the other leading to subsequent biochemical and physiologic 
events. This preparation is a fragment of neurons containing the neuronal membrane,   
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Figure 2. Hypothesis: Proposed nongenomic action of thyroid hormones in adult mammalian brain. 
 
Figure 3. (a) A typical neuron. (b) Cartoon of a neuron showing synaptosome. (c) Scanning electron 
microscopic image of synaptosome.  
Synaptic vesicles, and the other intracellular components (Figure 3). Synaptosomes can be 
considered as isolated nerve terminals. Synaptosomes are obtained after homogenization 
and fractionation of nerve tissue. The fractionation step involves several centrifugations 
steps to separate various organelles from the synaptosomes. Synaptosomes are formed from 
the phospholipid layer of the cell membrane and synaptic proteins such as receptors. 
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Synaptosomes are frequently used to study synaptic signal transduction pathways because 
they contain almost the entire molecular machinery necessary known for the uptake, 
storage, release of neurotransmitters, receptor properties, and enzyme actions etc. 
5. Subcellular levels of L-triiodothyronine (L-T3) and L-thyroxine (L-T4) 
in adult rat brain cerebral cortex  
As the brain approaches adulthood, nuclear iodothyronine concentrations gradually 
decreases reaching a plateau and maintains it, and the TH levels increase within nerve 
terminals of adult vertebrates [1,18-21]. It also demonstrated decrease in L-T3-binding in 
adult brain compared to developing brain. 
Although, evidence of transportation 125I-L-T3 and 125I-L-T4 within the nerve terminal was 
demonstrated following intravenous injection in adult rat brain [10,18,19,22], its euthyroid 
concentrations and subcellular distribution was never been evaluated until recently [13,23]. 
Intravenous administration of [125I]-L-T4 in rats followed by thaw mount autoradiography 
showed distribution of L-T4 in selective areas of adult brain in a saturable manner. 
Gradually L-T4 was concentrated more within nerve terminals fractions, where L-T4 was 
monodeiodinated to produce L-T3, the active form of TH [10]. L-T4 and L-T3 transportation 
within neurons are shown to occur by two different mechanisms. L-T3 is actively taken up 
in a saturable manner, while L-T4 transportation occurs by diffusion and in a non-saturable 
way. L-T4-transporation within the neuron is dependent upon L-T4-concentration gradient 
between extracellular and intracellular compartments and is maintained by high 
deiodination rate of L-T4 to L-T3 [24]. Role of transthyretin has also been described as a 
major binding protein in cerebrospinal fluid. Transthyretin has been implicated to facilitate 
L-T4 transportation across the blood-brain-barrier and finally into the brain. Recently MCT-
8 has been ascribed to be the most effective TH transporter [25]. These MCT-8 are 12 
transmembrane spanning proteins, and in particular plays a major role for very specific 
transportation of L-T3 within the neurons followed by the active conversion of the 
prohormone L-T4 to L-T3 by the D-II within the CNS [26]. D-II is essentially important for 
the conversion of the prohormone L-T4 into the active L-T3 within the CNS. However, 
understandings of the levels of THs within the neurons are imperative. This information is 
crucial to explore the role of L-T3 in neural signal transmission in mature brain. To help 
meet this requirement the following study was performed to quantify and compare the 
levels of THs in adult rat brain cerebral cortex.   
5.1. Comparison of the levels of L-tetraiodothyronine (L-T4) and L-
triiodothyronine (L-T3) in subcellular fractions 
While serm levels of L-T4 (~ 41 ng/ml) and L-T3 (~ 0.7 ng/ml) were found consistent with the 
normal peripheral results, this assay system could not detect L-T4 in either synaptosomal or 
non-synaptic mitochondrial fractions. However, the L-T3 levels in synaptosomes (0.450.06 
ng/mg synaptosomal protein), and non-synaptic mitochondria (1.440.12 ng/mg 
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mitochondrial protein) were significant. The levels of L-T3 in non-synaptic mitochondria 
were ~3.2-fold higher compared to synaptosomal values in cerebral cortices [13,16]. The 
finding of undetectable levels of synaptosomal L-T4 was consistent with other studies 
[14,27,28]. A higher fractional rate of D-II activity that converts L-T4 to L-T3 is attributed 
[29,30].  
This study quantifies the TH concentrations from adult rat brain synaptosomal and non-
synaptic mitochondria. Although L-T4 levels could not be detected in synaptosomal and non-
synaptic mitochondrial fractions, fair amounts of L-T3 were detected in these fractions purified 
from adult rat brain cerebral cortex [13,16]. Undetectable levels of synaptosomal L-T4 levels 
were also supported within synaptosomal fractions obtained from adult rat brain [27].  
Despite very low levels of TH in hypothyroid condition as determined by serum levels of TH, 
previous report has shown that L-T3 production in brain is pretty high in stress situations like 
hypothyroidism [13]. D-II has also been shown to be activated in other stressful conditions and 
indicated to have a protective role in stressed brain [31]. Stimulated levels of D-II have been 
described during hypothyroidism. This supports the first initial report [13] of elevation of 
brain L-T3 levels during n-propylthiouracil (PTU)-induced hypothyroid conditions [14,15,32]. 
In brain, approximately 80% of the L-T3 is produced locally from L-T4 by D-II. The fractional 
rate of conversion of L-T4 to L-T3 is remarkably high in brain [29]. This might be a possible 
reason for undetectable L-T4 levels due to rapid conversion of L-T4 to L-T3 in these fractions. 
To detect the endogenous TH levels the subcellular fractions were ruptured hypo-osmotically. 
The use of 8-anilinonaphtho-sulfonic acid in the radioimmunoassay medium excluded the 
possibility of the non-detectable protein bound form of the hormone by releasing the 
endogenously bound form of the hormones [13].  
Comparatively higher levels of L-T3 in the mitochondria may have implications on the 
mitochondrial bioenergetics such as, cellular oxygen consumption, oxidative 
phosphorylation and ATP synthesis, mitochondrial gene expression. These are few of the 
major regulatory functions of TH. THs also have been shown to affect mitochondrial 
genome mediated through imported isoforms of nuclear TH receptors and influence various 
mitochondrial transcription factors [3,33]. Concentration and localization of radiolabeled L-
T3 within the nerve terminal was the first landmark research described in adult rat brain. 
This further followed with the immunohistochemical mapping demonstrating locus 
ceruleus norepinephrine stimulating active conversion of L-T4 to L-T3. This established a 
morphologic co-localization of central thyronergic and noradrenergic systems. Overall TH 
levels within different compartment of brain may have discrete, differential and potential 
regulatory function for neurotransmission in adult mammalian brain [10].  
5.1.1. Thyroid hormone levels in hypothyroid rat cerebrocortical synaptosomes 
Synaptosomal levels of L-T3 were also studied in different thyroidal conditions. Serum 
levels of L-T3 and L-T4 confirmed establishment of peripheral hypothyroidism induced by 
14 days of intra-peritoneal (i. p.) injections of PTU (2 mg/g BW). However, surprisingly 
hypothyroid rat brain showed ~9.5-fold higher amount of L-T3 (126 nM) in synaptosomes 
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compared to euthyroid control values. A single i. p. injection of L-T3 (2 g/g BW) to the 
hypothyroid rats decreased the synaptosomal levels of L-T3 by ~1.6-fold compared to the 
hypothyroid rats and was still ~6-fold higher than the euthyroid value. An increase in ~2.5-
fold of the L-T3 levels was noticed in euthyroid plus L-T3 (2 g/g BW) group (Figure 4) [13]. 
Although the levels of L-T3 in whole rat brain homogenate was found to be in low 
nanomolar ranges [22], two concurrent reports estimated synaptosomal levels of L-T3 to be 
~14.6 nM [23], and ~13 nM [13] in adult rat brain synaptosomes. Observation of high levels 
of synaptosomal L-T3 were also supportive [15] in hypothyroid rat cerebral cortex by ~1.7-
fold compared to the control values maximally at day 4 of induction of hypothyroidism 
while the serum levels of L-T3 remained at the hypothyroid levels.  
Hypothyroid condition shows an appreciable decline in both serum L-T4 and L-T3 level in 
rats in a usual way as found by other investigators [34]. Although it has been shown earlier 
that in hypothyroid condition, the whole brain, or different regions of the brain, maintain 
similar levels of L-T3 compared to the euthyroid control rats through increased activity of 
D-II, and corresponding high fractional rate of L-T4 to L-T3 conversion [35,36], insufficient 
evidence is available except for a few recent reports  to quantitate the synaptosomal 
concentration of thyroid hormones. Approximately 8-fold higher concentration of L-T3 has 
been found in synaptosome compared to the whole brain in euthyroid rats. Our observation 
of approximately 9.5-fold higher L-T3 content in synaptosome of hypothyroid rats 
compared to the euthyroid controls may be the result of a higher fractional rate of L-T3 
production by increased activity of D-II, and a correspondingly higher selective uptake and 
concentration of L-T3 molecules in the synaptosomes to cope up with the physiological need 
of THs in this tissue at this condition [13,23,37,38].  
 
Figure 4. L-T3 levels in rat cerebrocortical synaptosomes in various thyroid states. (Ref. Sarkar and Ray 
1994, Neuropsychopharmacology 11: 151-155 acknowledged [13]).  
In euthyroid rat brain, selective uptake of 125I-L-T3 and its concentration in synaptosomal 
compartment have been demonstrated [10]. In addition, the use of hypothyroid animals 
only after 14 days of PTU treatment, where some adaptive mechanisms still unknown in 
nature prevail, do not reach the equilibrium as compared to the animals kept in chronic 
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hypothyroid condition for a much longer duration as used by other workers. This may be 
one of the reasons for maintaining a high level of synaptosomal L-T3 in our hypothyroid 
rats. Expression of the data in different forms such as per gram organ (brain) basis, or per 
mg compartmental (synaptosomal) protein basis, as presented in our experiment, also 
becomes an additive factor for discrepancies among different groups of workers regarding 
the quantitative aspects of L-T3 or L-T4 in the brain [23,34,38,39]. The fall in L-T3 
concentration in synaptosomes prepared from L-T3-treated hypothyroid rat cerebral cortex 
may be the result of inhibition of D-II activity after 24 hours of the L-T3 administration, in 
the presence of the considerable amount of exogenous L-T3. An inhibition in the activity of 
D-II has been noticed within 4 hours of L-T3 treatment to the thyroidectomized rats. A rise 
in the synaptosomal L-T3 level in the hypothyroid rats, and a fall in the same in the L-T3-
treated hypothyroid animals after 24 hours of L-T3-treatment, also reflects the tendency for 
a compensatory regulatory mechanism of thyroid hormone metabolism in the adult rat 
brain in altered thyroid conditions, although the nature of the mechanism remains 
unknown. L-T3-treated control rats have shown higher levels of synaptosomal L-T3, 
compared to the control values. This may be a result of the extra L-T3 transport influenced 
by a high dose of exogenously administered L-T3 (2 g/g) [18,19,24].  
Observation of undetected levels of L-T4 within cerebrocortical synaptosomes may reflect a 
state of rapid conversion of L-T4 to L-T3 in the brain by D-II enzyme. Other researchers have 
already shown that after intravenous administration of radiolabeled L-T4 and L-T3, the 
hormone is concentrated as L-T3 in a synaptosomal fraction of the whole rat brain, and L-T4 
to L-T3 conversion occurs very rapidly within the nerve cells. L-T3 formed in the neuronal 
cell body then may be translocated down the axon to the synaptic ends. Saturable and 
nonsaturable uptake of L-T3 and L-T4 in isolated synaptosomes in an in vitro model also 
indicated two-component L-T3-uptake system [18,19,24,37,38].  
The prediction of a role of D-II as suggested [13] is further supported by few other studies 
[15,31]. Increased D-II activity is suggested in hypothyroid brain. This is attributed to the 
maintenance of normal brain concentrations of L-T3 even under low peripheral levels of L-
T4 [31]. The high level of L-T3 as observed by us is supported and suggested for 
maintenance of brain homeostasis. This demonstrated onset of a central homeostasis for THs 
in adult hypothyroid brain between the 1st and 2nd day, its maintenance for about 16-18 days 
and thereafter declined between the 18-20th day [15]. This report also confirms and confers 
higher activity of D-II (~ 1.6-fold higher compared to control) within the cerebrocortical 
synaptosomal fraction during short-term brain-hypothyroidsm. It is described as a 
protective mechanism of brain by raising the brain L-T3 levels. Another study also 
documents an increase in D-II activity within various brain regions and decrease in D-III 
activity, except in cerebrellum and medulla where specific D-III activity remained 
undetected [40]. However, controversially, although these investigation did observe higher 
D-II activity within various areas of adult brain during hypothyroidism, the changes in L-T3 
levels remained lower than normal values as was noticed in case of serum levels of 
hypothyroidism. This investigation could not explain this high D-II activity and lower L-T3 
levels in brain regions. The levels of THs measured in this study also were shown to be 
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lower than found by other investigators. Some assay in brain regions was also performed in 
tissue homogenates instead of particular subcellular fractions. Possibly differences in the 
concentrations of THs could be due to a different method of severe extraction procedure 
employed to extract brain tissue THs resulting in loss of it.  
The data emerged from our study reveal the quantitative aspects of involvement of L-T3 in 
synaptosomes in different thyroid states, and favors its role in neuronal functions as 
formerly described [10,41]. A stimulation of synthesis of synapsin-1 protein (related to 
neurotransmission) by L-T3 in the developing brain has been reported [42]. Although, the 
synaptosomal L-T3 levels varied widely with different treatments, our result illustrates a 
unique, but unknown regulatory mechanism of the TH metabolism in the mature 
mammalian brain. 
5.2. Modulation of neuronal plasma membrane Na+-K+-ATPase specific activity 
as a function of specific binding of L-triiodothyronine in adult rat brain 
cerebrocortical synaptosomes  
Subsequently the idea of concentration, distribution and metabolism of THs within the 
mature brain generated interest to search for potential role of TH and its nongenomic 
interaction, if any, with neuronal plasma membrane. TH is well known for its regulation of 
energy metabolism in developing tissues including brain. However, adult brain has not 
shown this effect on energy metabolism under the influence of TH until recently. 
Maintenance of ionic gradients by plasma membrane Na+-K+-ATPase (NKA) is one of the 
important cellular events by which TH regulate energy metabolism. NKA is an ion pump 
responsible for maintaining Na+ and K+ ion gradients across the cellular plasma membrane 
in eukaryotic cells. The Na+ and K+ ion gradients are important for establishment of resting 
membrane potentials as well as for transport of certain molecules. NKA has special 
significance in maintaining membrane potentials in neurons. Inhibition of NKA has been 
shown to release acetylcholine [43] and norepinephrine [44] from rat cortical synaptosomes, 
presumably as a result of depolarizing effects of lowered K+ gradients. The level of NKA 
activity could therefore have consequence for the regulation of the neurotransmitter release 
and uptake across the synaptic membrane [43].  
5.2.1. In vivo and in vitro actions of L-T3 on synaptosomal Na+-K+-ATPase activity  
A dose-dependent inhibition of synaptosomal NKA activity by L-T3 both in in vivo [45], and 
in in vitro [46] conditions have been shown. This may be related to the differences in L-T3 
status in adult rat cerebrocortical synaptosomes. L-T3 administration in a single i.p. injection 
showed inhibition of synaptosomal NKA specific activity maximally at 24 hours post-
injection by ~ 44% compared to respective control euthyroid values. A range of L-T3 
concentration (0.1 to 4.0 g/g BW, single i. p. injection) administered in vivo showed dose-
dependent inhibition of the synaptosomal NKA activity. In contrast PTU-treated 
hypothyroid animals showed ~ 38% increase in the NKA activity compared to the control 
values. This increase in NKA activity was abolished by injection of a single L-T3 injection 
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(2g/g BW) to almost close to the euthyroid levels. However, this study could not 
distinguish between the genomic and nongenomic effects of L-T3. TH has also been 
reported to influence K+-evoked release of [3H]-GABA in adult rat cerebrocortical 
synaptosomes. Such evidence indicates a possible role of TH in neurotransmission in adult 
mammalian brain. A functional correlation between L-T3 binding and the corresponding 
inhibition of NKA activity under in vitro conditions in the synaptosomes of adult rat 
cerebral cortex were established [46]. To further test the hypothesis of nongenomic action of 
TH we investigated NKA activity in isolated synaptosomes which is devoid of nucleus to 
avoid the chances of nuclear activation [46]. In fact, in vitro addition of L-T3 (1x10-12 M to 
10x10-8 M) within 10 minutes of incubation indicated a dose-dependent inhibitory response 
to NKA activity. Such immediate action of L-T3 added in in vitro in synaptosomes was 
concluded as rapid nongenomic action of L-T3 on synaptosomal membrane NKA [46]. 
Further inhibition of NKA activity was corroborated with gradual binding of [125I]-L-T3 to 
specific L-T3-binding sites in synaptosomes. Thus a physiologic response tied to the specific 
L-T3-binding in the synaptosomal membrane was demonstrated.  
The presence of high affinity low capacity nuclear TH receptors in adult rat brain has been 
reported. Further evidence shows selective uptake of [125I]-L-T3 and rapid conversion of L-
T4 to L-T3   in synaptosomal fraction of adult rat brain. Specific [125I]-L-T3 binding sites have 
also been demonstrated in the synaptosomes of adult rat brain [47] and chick embryo [48]. 
However, no functional relationship could be established due to the interaction of TH and 
its membrane receptor so far in adult brain.  
Scatchard plot analysis demonstrated two sets of specific L-T3 binding sites: one with high 
affinity (Kd1: 12 pM; Bmax1: 3.73±0.07 fmols/mg protein), and the other with low affinity (Kd2: 
1.4±0.05 nM; Bmax2: 349±7 fmols/mg protein). Kd represents dissociation constant. Bmax 
represents maximum binding capacity. Rationale between gradual L-T3 binding and the 
corresponding dose-dependent L-T3-induced inhibition of synaptosomal NKA was 
established in vitro [46].  
The relative order of potencies of binding affinities for the synaptosomal L-T3 binding sites 
and relative inhibition of NKA activity in the presence of different  L-T3  analogues were as 
follows: L-T3>L-T3-amine>L-T4=L-TRIAC>r-T3>L-T2, and L-T3>L-T3-amine>L-T4>L-
TRIAC>r-T3>L-T2, respectively. The concentrations of TH analogues required to displace 
50% specific binding (ED50 value) of 125I-L-T3 to its synaptosomal binding sites were 10-, 63-, 
63-, 1000- and 6250 nM, respectively. This study showed the nature of inhibition of 
synaptosomal NKA activity as a function of L-T3 occupancy of synaptosomal receptor sites 
in mature rat brain [46].  
This investigation demonstrates a novel action of TH in mature rat brain. This is the first 
report presenting a relationship between the inhibitions of synaptosomal NKA as a 
functional effect of L-T3 binding to its synaptosomal receptor in the cerebral cortex of adult 
rat. Occupancy of specific high affinity L-T3 binding sites demonstrated a concentration-
dependent inhibition of the NKA activity with a maximum of 59%. At 1x10–10 M L-T3 
concentration the enzyme inhibition was ~35% and the saturation of the L-T3 binding sites 
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was ~74%. This appears to be physiological. Further inhibition of NKA activity as found 
with higher concentrations of L-T3 (5x10–10 – 1x10–7 M), corresponds to the increase in the 
occupancy of the L-T3 binding sites (maximum of ~80%) at the low affinity binding range. 
However, this site was not saturated by 15.4 M L-T3 used for determining non-specific 
binding. Hence, it is possible that this low affinity binding is due to non-specific effects of 
several other proteins located in synaptosomes. The relationship between the binding of L-
T3 to its synaptosomal binding sites and the concentration dependent inhibition of the 
enzyme activity appears to hold good only with the occupancy of high affinity sites up to 5 x 
10–10 M L-T3 [46]. Synaptosomes prepared from chick embryo cortex were also reported to 
have two sets of L-T3 binding sites [48]. Their properties and ontogeny showed a marked 
difference from those of nuclear receptors. Even though NKA activity was suppressed 
beyond the saturating concentration of L-T3 at high affinity binding sites, this may be non-
specific and non-physiological. The relative order of binding affinities for TH analogues to 
the L-T3 binding sites and the inhibitory potencies for NKA activity were also correlated in 
the synaptosomes. L-T3-amine was used to examine its potency to inhibit specific [125I]-L-T3 
binding in synaptosomes with the idea that it may be a decarboxylated product of L-T3 and 
may have actions like L-T3. The ED50 value for L-T3-amine was determined as 10 nM. At this 
dose, L-T3-amine also inhibited the synaptosomal NKA activity by ~51% compared with L-
T3. This result is also in good agreement with earlier studies, in which L-T3-amine was 
shown to be ~71% as effective as L-T3 in stimulating Ca2+-ATPase activity at a dose of 10 nM 
in human RBC [49]. In earlier studies, L-T3-induced increase in NKA activity in the 
developing brain [50] and kidney cortex [51] of rat was reported to be due to an increase in 
the mRNA levels of , + and -subunits of the enzyme, while the NKA in adult was not 
responsive to L-T3. However, a dose-dependent inhibition and regulation of synaptosomal 
NKA activity in different in vivo situations was noticed. The immediate effect of added L-T3 
on the synaptosomes appears to be nongenomic as synaptosomes do not have nuclei. This 
may exclude the possibility of involvement of nuclear receptors as reported earlier by us. 
One possible effect of L-T3 may be mediated through membrane receptors. Recently, 
membrane binding proteins for iodothyronines has been described in plasma membranes of 
most cells [52]. This protein has been designated as an integrin V3. Also a role of MCT-8, 
a membrane spanning protein, has been ascribed as a very active and specific transporter of 
THs and some of its metabolites across the membrane [25,53]. However, its action through 
cytoplasmic L-T3-responsive proteins cannot be ruled out.  
In conclusion this study demonstrates, for the first time, a correlation between the binding of 
TH to its putative receptors and inhibition of NKA activity in the synaptosomes of adult rat 
brain [46]. This may have implications in the involvement of thyroid hormone on important 
mental functions in adult mammalian brain. 
5.3. In search for possible second messenger mediated events in synaptosomal L-
T3-induced signaling 
The evidence of L-T3-synaptosomal membrane interaction in association with the inhibition 
of the synaptosomal membrane NKA activity led us to search for if the L-T3-induced action 
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is mediated via activation or regulation of the second messenger cascade systems. Besides 
the cyclic nucleotide cyclase systems calcium (Ca2+) also plays an important role in cellular 
signal transmission. Ca2+-influx is a major event in neurotransmission. Keeping such visions 
we further intended to explore the role of Ca2+ in L-T3-induction.  
5.3.1. Effect of L-T3 on synaptosomal Ca2+-influx: A comparison between euthyroid and 
hypothyroid brain 
Metabotropic events are often initiated at the membrane level, mediated and amplified 
through G-protein coupled receptors (GPCR) and/or ion channels followed by activation of 
second messenger system and subsequent substrate protein phosphorylation. Ca2+-influx is 
an important physiological function in brain, following which cascades of membrane events 
occur finally leading to neurosignaling. Disruption in this crucial membrane phenomenon 
may lead to variety of Ca2+-dependent neuropsychological disorders. Although TH-
mediated Ca2+ entry in adult rat brain synaptosomes [54,55], and in hypothyroid mouse 
cerebral cortex [56] have been reported, it’s synaptic functions in adult neurons in 
dysthyroidism is unclear. Keeping in mind the role of Ca2+ ions as a messenger in the 
signaling pathway the effect of L-T3 on intracellular Ca2+-influx, in vitro, was studied.  
 
Figure 5. Effect of L-T3 on intrasynaptosomal Ca2+-concentration in euthyroid and PTU-induced 
hypothyroid rat cerebral cortex in vitro (Ref. Modified from Sarkar and Ray 2003, Hormone and 
Metabolic Research 35: 562-564 acknowledged [57])).  
Our study demonstrates a regulation and homeostatic mechanism of Ca2+ accumulation 
within cerebrocortical synaptosomes of hypothyroid adult rat [57]. Application of brain 
physiologic concentrations of L-T3 (0.001 nM to 10 nM), in vitro, significantly triggered Ca2+-
sequestration both in the euthyroid and hypothyroid rat brain synaptosomes in a dose-
dependent manner (Figure 5). Unexpectedly, PTU-induced hypothyroid synaptosomes 
showed significant levels of increase in Ca2+-influx compared to euthyroid controls between 
0.1 nM and 10 nM doses of L-T3. However, 0.001 nM dose of L-T3 did not show significant 
changes between euthyroid and hypothyroid values.  
Present study validates the role of Ca2+ ions under the influence of L-T3 in the synaptosomes 
from adult rat brain cerebral cortex. L-T3-induced dose-dependent Ca2+-entry both in 
euthyroid and PTU-induced hypothyroid rat brain synaptosomes at low L-T3 doses (0.001 
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nM to 10 nM). This evidence indicates role of Ca2+ as a second messenger in synaptic 
functions. L-T3 also has been documented to increase 45Ca uptake and Ca2+-influx in adult 
euthyroid rat synaptosomes, and in hypothyroid mouse cortex. An enhancement of nitric 
oxide synthase (NOS) activity in adult rat cerebrocortical synaptosomes was shown [55]. 
This present study demonstrated a significant increase in Ca2+ accumulation in hypothyroid 
rat brain cerebrocortical synaptosomes compared to euthyroid control at below (0.1 nM) and 
at about brain physiologic concentrations (10 nM) of L-T3. At present clear understanding 
for the L-T3-induced release of intracellular calcium is not known; however possibility for L-
T3-induced action in neuronal cells cannot be left out. Use of sodium azide blocked any 
mitochondrial accumulation of calcium. Our earlier studies have shown that 10 nM and 100 
nM dose of L-T3 could saturate the specific synaptosomal L-T3-binding sites by ~69% and 
~74% respectively. L-T3-mediated physiological increase in synaptosomal Ca2+ accumulation 
could be attributed to receptor-mediated physiological response having its maximal effect at 
10 nM dose of L-T3. The differences in the observation of increased rate of Ca2+ 
accumulation in hypothyroid synaptosomes compared to the euthyroid values reflected an 
adaptive mechanism. This could be credited to homeostatic mechanism to overcome PTU-
induced stress conditions persisted in the adult neuron. High intrasynaptosomal L-T3 level 
(~9.5-fold higher; 2.56 ng/mg synaptosomal protein 126 nM L-T3) could be one of the 
reasons. Although hypothyroid condition showed an appreciable decrease in both serum 
levels of L-T4 and L-T3 as predicted, supportive studies showed maintenance of similar 
levels of brain L-T3 in hypothyroid conditions through increased activity of D-II suggesting 
high fractional rate of L-T4 to L-T3 conversion. In brain approximately ~80% of L-T3 is 
produced locally from L-T4 by D-II. This data supports thyroid hormone-Ca2+-ion 
interaction for normal functioning of adult brain during different neuropsychological 
conditions.  
The important functional role of Ca2+ and several calcium-dependent proteins in neuronal 
signal transduction are well recognized. Ca2+ has been shown to inhibit neuronal NKA 
activity. Ca2+-influx also lead to Ca2+-dependent activation of protein kinase C and/or 
Ca2+/CaM-dependent protein kinases followed by direct or indirect activation of 
phosphorylation of several target proteins. This indicated a rapid nongenomic action of L-
T3.  
5.3.2. Is thyroid hormone-membrane interaction is linked to G-protein coupled receptors 
(GPCR)? 
5.3.2.1. Association of G proteins with membrane receptors 
G proteins are GTP-binding proteins that couple activation of seven-helix receptors by 
neurotransmitters at the cell surface for the activation of the effector enzymes-adenylate 
cyclase (AC) or guanylate cyclase (GC), which synthesize the corresponding cyclic 
nucleotides, cAMP or cGMP respectively and regulate protein kinases., such as protein 
kinase A (PKA), protein kinase C (PKC) etc. Metabotropic events are often initiated at the 
membrane level, mediated and amplified through GPCR followed by activation of second 
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messenger system and subsequent substrate protein phosphorylation. Phospholipase C 
(PLC), another effector enzyme, generates inositol triphosphate (IP3) and diacylglycerol 
(DAG), the latter of which releases intracellular stores of calcium. The cAMP, cGMP, Ca2+, 
DAG and IP3 act as second messengers and activate protein kinases with broad substrate 
specificity. The kinases phosphorylate key intracellular proteins, including ion channels, 
enzymes, and transcription factors which modulate cellular biological processes [58,59]. 
Guanine nucleotides are known to have dual effects on most hormone-sensitive AC systems. 
This modulates activation of AC and binding of hormone to receptor. In neuronal 
membranes guanylate nucleotides has been shown to be required for the stimulation of AC. 
However, no modulation of TH binding at appropriate guanylate nucleotide concentrations 
has been reported. It is well established that cholera toxin enhances the activity of Gs 
(stimulatory G protein -subunit) by ADP-ribosylating Gs subunit and inhibiting GTPase 
activity associated with the protein. This increases cAMP production.  
The activity of NKA is regulated by various catecholamines [45,46,60] as well as by L-T3 
[45,46]. Inhibition of NKA has been demonstrated in intact cell preparations by phorbol 
esters, dibutyryl cAMP, and phospho-DRPP-32 (dopamine- and cAMP-regulated 
phosphoprotein of molecular weight 32 kD), a protein phosphatase inhibitor [61-63].  
Some information focuses to effect of TH or its metabolites on noradrenergic like responses. 
This idea develops since TH has possibility to produce a family of biogenic amine-like 
neurotransmitter compounds catalyzed by aromatic amino acid decarboxylase, such as 
iodothyronamines. Physiologic identification of these family of TH-derived 
iodothyronamines have not yet been discovered until recently in rat brain and in rat and 
human blood. These two compounds are monoiodothyronamine and thyronamine [10]. 
Thinking this could be a possibility before this identification of monoiodothyronamine and 
thyronamine were reported we studied the effect of L-T3 on synaptosomal NKA activity 
using various - and -adrenergic agonists and antagonists known to regulate Gs and Gi 
proteins of the neuronal signal transduction system, in vitro.  
Our studies showed that although both L-T3 and isoproterenol (-adrenergic receptor 
[ADR] agonist and activator of Gs-protein) similarly inhibited synaptosomal NKA activity, 
propranolol (-ADR antagonist) could only block the effect of isoproterenol, but not the 
effect of L-T3. Instead propranolol produced a dose-dependent potentiation of the inhibitory 
influence of L-T3 (Figure 6). The augmentation of L-T3-effect by propranolol appeared to be 
a type of synergistic action and it might be due to some changes in the pre-synaptic 
membrane properties, the mechanism of which is unclear at present. However, clonidine 
(2-ADR agonist, and Gi-protein activator) (Figure 7) and glutamate (acts through 
metabotropic glutamate receptors and activator of Gi protein) (Figure 8) attenuated L-T3-
effect, suggesting its possible coupling with GPCR. Equimolar concentration of clonidine  
(1 nM – 100 nM) counteracted the inhibitory effect of L-T3 on the NKA activity (Figure 7). 
This counteraction by clonidine, 2-ADR agonist, appears to be mediated through the 
inhibition of adenylate cyclase activity with the activation of inhibitory G protein (Gi) 
followed by inhibition of cAMP synthesis and protein phosphorylation cascade mechanism. 
It is known that 2-adrenergic receptor agonist system act through Gi protein activation [64].  
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Figure 6. In vitro effect of L-T3, isoproterenol (ISO) and propranolol (P), on synaptosomal NKA activity. 
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Figure 7. In vitro effect of L-T3, clonidine (CLON, and yohimbine (YOH, 2-ADR antagonist) on 
synaptosomal NKA activity.  
Thus it seems that the L-T3 action could be ascribed more to stimulate Gs protein during 
beta-blockade which might be directed to manage this adverse condition. The results also  
suggest that the L-T3-effect on the synaptosomal NKA activity was not mediated via the -
ADR-dependent systems, since it was not blocked by propranolol. Based on these results it 
was also hypothesized that L-T3-effect would alter adenylate cyclase activity. In cultured 
neuroblastoma plasma membrane increased adenylate cyclase activity was noticed followed 
by L-T3-treatment [65]. In fact, later, increased adenylate cyclase activity was noticed in 
brain hypothyroid condition which increases brain L-T3 levels. This observation was 
correlated well with increased D-II activity to the increased brain L-T3 levels in brain 
hypothyroid situations [15]. Guanosine 5'-O-(3-thiotriphosphate) or pertussis toxin also has 
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been reported to inhibit TH-induced mitogen-activated protein kinase (MAPK) 
phosphorylation nongenomically in 293T cells which is consistent with a cell membrane 
mechanism mediated via a G-protein [66]. 3-iodothyronine (T1AM), an endogenous and 
rapid-acting derivative of TH, is associated with Gs-protein coupled-trace amine receptor 
TAR1 in HEK cells. However, no modulation of TH binding at appropriate guanylate 
nucleotide concentrations in adult brain has been reported [67]. Determination of whether 
activation or inactivation of a specific type(s) of G-protein influences TH-effects on protein 
phosphorylation is crucial.  
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Figure 8. Attenuation of L-T3-effect on synaptosomal NKA activity by glutamate, in vitro. 
A diverse nongenomic effect of TH has been observed in non-neural tissues including liver, 
heart, adipocytes, and blood [12,68]. Some possible nongenomic actions of THs include 
modulation of GABA uptake, regulation of NKA activity and increase of presynaptic Ca2+-
influx. In synaptoneurosomes TH inhibits the stimulation of chloride flux by GABA [69]. L-
T4 has been shown to stimulate the MAPK pathway in a variety of cultured cell lines 
including HeLa and CV-1 cells which lack functional nuclear TH receptors [66,70-73], 
consistent with a cell membrane mediated mechanism via G-proteins. L-T4 and L-T3 were 
found to inhibit Go-protein activities in synaptosomes from developing chick brain [48].  
Direct interactions of G protein subunits with Ca2+-channels are not well documented. 
However, increased evidences showed receptor activated G proteins modulate activities of 
ion channels by membrane-confined mechanisms [74]. Isoproterenol induced 
phosphorylation of ventricular Ca2+-channels via PKA has been reported [75]. Gs protein 
also has been shown to regulate Ca2+-channels both in a cAMP-independent membrane-
confined mechanism [74] and in a cAMP-dependent phosphorylation of one of the subunits 
of L-type Ca2+-channel [76]. Synaptosomal NKA has previously been described to be 
inhibited by cAMP in a dose-dependent manner suggesting a role of PKA. The activated 
form of this protein kinase was further phosphorylated a substrate protein which in turn 
depressed the total Na+-dependent phosphorylation of the synaptosomal NKA [77]. Overall, 
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our data indirectly support the involvement of second messenger system (cAMP and/or 
Ca2+) mediated through G protein activation after specific L-T3-membrane receptor 
interaction. The membrane NKA has been implicated in several aspects of physiologic 
processes including its role in neurotransmitter release [43].  
5.4. First evidence of rapid nongenomic action of thyroid hormone and its 
metabolites on the synaptosomal protein phosphorylation in adult rat brain, in 
vitro 
Protein phosphorylation and dephosphorylation are now recognized to be major regulatory 
mechanisms by which neural activities are controlled by external physiological signals or 
stimuli. Several nongenomic mechanisms are coordinated by rapid post-transcriptional 
modifications, such as protein phosphorylation and dephosphorylation reactions, which act 
like a molecular switch to control intracellular signaling mechanisms. Abnormalities of these 
imperative regulatory signaling processes produce deleterious effects on the CNS. As a 
consequence, variety in unusual protein phosphorylation is the end result of many major 
neuropshychological dysfunctions leading to diseases [78]. Numerous second messenger 
molecules regulate cellular physiology by effects on protein kinases and phosphatases. 
Protein kinases catalyze the transfer of the terminal -phosphate group of ATP or GTP to the 
hydroxyl group of serine, threonine or tyrosine in substrate proteins. Their structure, 
subcellular localization and substrate specificity allow them to control cellular physiology. 
These proteins largely make up the cell signaling pathways that transmit, amplify and 
integrate signals from the extracellular environment. Protein phosphorylation promotes 
enzyme activation or deactivation. Phosphorylated proteins are substrates for protein 
phosphatases and dephosphorylation occur to serve as a molecular switch to fine tune a 
cellular response [79].  
Variety of agents regulating the activity of NKA raises the possibility of the NKA as a 
substrate molecule that is subject to regulation by phosphorylation or dephosphorylation. 
Indeed, inhibition of NKA is associated with the phosphorylation of the enzyme by both 
PKA and PKC. This inhibition of NKA has been attributed to the phosphorylation of 1-
subunit of the NKA molecule at serine residues by PKA and PKC site-specifically. 
Isoproterenol (-adrenergic agonist that activates adenylate cyclase to produce cAMP, an 
activator of PKA), forskolin (adenylate cyclase activator), and okadaic acid (an inhibitor of 
protein phosphatase-1 and -2A) have been reported to increase significantly the level of 
phosphorylation of wild-type 1-subunit of the NKA in COS cells, accompanied by a 
significant inhibition of the enzyme activity [62,63]. Among nine distinct isoforms of 
adenylate cyclase (AC), three isoforms are Ca2+/calmodulin-dependent, including type I-AC, 
III-AC [80,81], and VIII-AC. The Ca2+/calmodulin-dependent AC is an integral membrane 
protein [82]. Hence, one possible role of Ca2+/calmodulin may be to stimulate 
Ca2+/calmodulin-dependent AC followed by cAMP production and phosphorylation of the 
NKA, exactly as -adrenergic receptor agonists do. 
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While a direct effect of TH on protein kinase activity has not been formerly studied in 
tissues from mature brain, hypothyroidism has been linked with reduced levels of 
phosphorylated MAPK in the hippocampus [83]. Based on these observations, possibility of 
a metabotropic pathway for rapid actions of TH on protein phosphorylation in 
synaptosomes from adult rat brain was investigated.  
 
Figure 9. Representative autoradiogram of SDS-PAGE separation of proteins incorporating 32P in the 
presence of L-T3. Lanes were loaded with synaptosomal lysates which had been preincubated at 0°C for 
60 min and 37°C for 5 min with (from left): 1mM Na3VO4 (V), 1, 3, 10, 30, 100, 300, 1000, or 0 (C = 
control) nM L-T3 and then incubated with 20μM of [γ-32P]-ATP (3 μCi) for 1 min at 37°C. Left panel (a): 
Silver-stained gel for visualization of protein bands. Right panel (b): Autoradiogram of same gel 
showing increased incorporation of 32P in four prominent bands (α: 381 kD, β: 531 kD, γ: 631 kD, δ: 
1131 kD). (c) Normalized data showing effect of in vitro addition of graded doses of L-T3 on the levels 
of protein phosphorylation expressed as optical density (OD)/protein (Ref. Sarkar et al. 2006 
Neuroscience 137: 125-132 acknowledged [11]).  
Our observation demonstrated that TH induces rapid changes in synaptosomal protein 
phosphorylation. Incubation with L-T3 or L-T4 specifically showed significant biphasic 
dose-dependent effects on the phosphorylation of 381, 531, 621, and 1131 kD proteins. 
In vitro brain physiologic concentrations of TH (1-30 nM) showed significant increase in the 
levels of protein phosphorylation rapidly within minutes (Figure 9). In contrast, incubations 
with similar doses of reverse-T3 (rT3) were without significant effect, indicating specificity 
for L-T3 and L-T4. The protein phosphorylation statuses of these four synaptosomal 
(a) (b)
(c)
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proteins were significantly increased followed by L-T3 and L-T4 treatment as well. Both L-
T3 and L-T4 indicated bi-phasic nature of effect for each of these proteins phosphorylated. 
Maximum levels of phosphorylation were noticed at concentration range from 10-30 nM. 
However, no significant effect on protein phosphorylation was observed as an effect of rT3 
on any of these proteins. This effect of rT3 clearly confirmed very structural and functional 
specificity of L-T3 on protein phosphorylation. Determination of time course of protein 
phosphorylation followed by one single in vitro dose of L-T3 showed it peaked rapidly 
between 180 seconds to 240 seconds and thereafter it decreased. This indicated a rapid 
action of THs and its metabolites [11].  
Our next interest was to see which amino acids present in these phosphoyraled proteins are 
targets. Hence phospho-specifc antibodies for tyrosine and serine were used in western bolt 
analysis. Immunoblot analysis of synaptosomal lysates incubated with L-T3 (1 nM-1 M) 
confirmed phosphorylation at the seryl residues of a ~112 kD protein and phosphorylation 
at tyrosyl residues of a distinct ~ 95 kD protein. These data support that THs have a 
diversity of rapid nongenomic pathways for regulation of protein phosphorylation in 
mature mammalian brain [11]. Especially, the α-subunit of NKA is a ~112 kD membrane 
protein. Indeed, inhibition of NKA is associated with the phosphorylation of its subunits by 
both PKA and PKC. This inhibition of NKA has been attributed to the site-specific 
phosphorylation of the α1-subunit of the NKA at seryl residues by PKA and PKC [61-63]. In 
adult rat alveolar epithelial cell L-T3 induced translocation of NKA to plasma membrane. 
NKA stimulation by L-T3 was assigned to L-T3-induced stimulation of PI3K/PKB pathway 
via the Src family of tyrosine kinases nongenomically [84]. These data suggest possible 
involvement of membrane components in TH-induced protein phosphorylation.  
Examples of nongenomic control of protein phosphorylation by L-T3 also have been 
reported in few other tissues. Nongenomic relationship of MAPK and MAPK-mediated 
protein phosphorylation at the seryl residue of nuclear TH receptor has been described in 
293T cells [68]. This indicated a control of nongenomic mechanism on genomic mechanism. 
In developing brain, inhibition of PKA transcriptionally blocked L-T3-induced actin gene 
expression, whereas PKC and tyrosine kinase did not influence it significantly [85]. 
5.4.1. Thyroid hormones rapidly modulate synaptosomal protein phosphorylation via 
second messenger systems  
In other studies, L-T3 induction has also been shown to nongenomically regulate Ca2+ influx 
and nitric oxide synthase activity within seconds in adult rat brain [57]. Thus, THs are likely 
to have numerous rapid nongenomic effects on signaling mechanisms in neural tissue, 
including alterations in the levels of intracellular second messengers (cAMP and Ca2+) which 
regulate cAMP- and/or Ca2+/calmodulin (CaM)-dependent protein kinases leading to protein 
phosphorylation. Effects of TH on Ca2+-dependent activation of PKC and/or Ca2+/CaM-
dependent protein kinases are also possible, followed by direct or indirect activation of 
phosphorylation of the proteins. Thus further investigation demonstrated for the first time 
the rapid nongenomic second messenger mediated regulation of protein phosphorylation by 
 
“Quo Vadis?” Deciphering the Code of Nongenomic Action of Thyroid Hormones in Mature Mammalian Brain 23 
TH in mature mammalian brain and provided additional support for the contention that TH 
has a unique and complex signaling function in adult brain [12]. 
5.4.1.1. Role of calcium and calmodulin on synaptosomal protein phosphorylation, in vitro 
Many nongenomic mechanisms are modulated by phosphorylation–dephosphorylation of 
substrate proteins. Multiple Ca2+/calmodulin (CaM)-dependent protein kinases (CaM 
kinases) and Ca2+/phospholipid-dependent protein kinases (PKCs) have been identified in 
brain. Among these, CaMPK-II is the most abundant Ca2+/CaM-stimulated protein kinase in 
brain. CaMPK-II is important in several neuronal functions, including neurotransmitter 
release and the modulation of the functional properties of ion channels and receptors. 
CaMPK-II is differentially expressed in different brain regions of cells, exists in both 
cytosolic and membrane-associated forms and is especially concentrated in the postsynaptic 
density and synaptic vesicles. A distinct property of CaMPK-II is that autophosphorylation 
of its threonine residue near the calmodulin binding domain converts it to a Ca2+-
independent state. Further, it has been shown that calmodulin-dependent 
autophosphorylation of CaMPK-II induces a conformational changes in the region of the 
calmodulin binding domain that allows additional stabilizing interactions with calmodulin. 
This autophosphorylation may involve in extending the effects triggered by a transient 
calcium signal. PTU-induced mild hypothyroidism in chick brain during posthatch 
development has been shown to increase the level of Ca2+/CaM-stimulated phosphorylation 
in cytosol, but lower it in the membrane, indicating a role of thyroid hormones in 
distributing CaMPK-II during developmental changes [78,86].  
5.4.1.1.1. Effect of L-T3 on total protein phosphorylation 
The effect of Ca2+ and calmodulin on TH-induced total protein phosphorylation and their 
regulation was explored. L-T3 significantly and dose-dependently (10 nM-1 M) increased 
total 32P- incorporation into synaptosomal proteins, in vitro, over the basal level of 
phosphorylation. Although L-T3 exerted its own independent effect on increase in overall 
total protein phosphorylation, specifically it established its role to be at least dependent on 
Ca2+ and calmodulin. Ca2+ also showed its independent influence on the basal L-T3-induced 
total protein phosphorylation in synaptosomal isolates. The dependency of L-T3-induced 
total synaptosomal protein phosphorylation was evaluated and finally confirmed using 
EGTA (Ca2+-ion chelator) and KN-62 (a specific blocker of CaMK-II). In vitro addition of 10 
nM and 100 nM doses of L-T3 alone did not alter significantly the basal levels of 
phosphorylation. However, the 1 M dose of L-T3 significantly amplified the signal by ~1.3-
fold compared to the basal level (P<0.05). Next, we wanted to determine whether Ca2+ 
augments protein phosphorylation in the presence of L-T3. Ca2+ (0.5 mM) were able to 
significantly increase the basal phosphorylation level. However, no further significant 
changes were noticed with additional 10 nM or 100 nM L-T3. However, 1 μM concentration 
of L-T3 augmented the signal significantly (P<0.05) by ~1.5-fold (0.2167 pmols/min/mg 
protein) as compared to the Ca2+-treated baseline (0.1475 pmols/min/mg protein), and by 
~2.2-fold over the basal phosphorylation (0.097 pmols/min/mg protein). In contrast, the 
effects of low physiological concentrations of L-T3 were dramatically enhanced when 2 M 
CaM was added to the Ca2++ L-T3-treatment group. In the presence of Ca2+ and CaM, L-T3 
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(10 nM-1 μM) induced a dose-dependent increase in 32P- incorporation into synaptosomal 
protein, by 47±8 , 74±13 and 52±11 % (F = 6.77, P<0.0001) rapidly within 1 min compared 
with the Ca2+/CaM-treated control phosphorylation (0.189 pmols/min/mg protein) [87].  
Physiological concentrations L-T3 in nerve terminals are difficult to measure. Predictable 
levels of L-T3 within the nerve terminals range from ~10 nM to 64 nM. PTU-induced 
peripheral hypothyroidism in adult rats showed endogenous synaptosomal level of L-T3 is 
about ~126 nM. Thus L-T3 (1 μM) is well above this range, and would be considered to have 
a more pharmacological type of action on 32P- incorporation to synaptosomal 
phosphoproteins. Treatment with agents regulating Ca2+ could be a potential strategy for 
enhancing clinical treatment of conditions, such as certain affective disorders, which may be 
responsive to pharmacological doses of TH. In an earlier in vitro study, L-T3 doses (0.1 to 
100 nM), have been shown to induce an increase in intrasynaptosomal Ca2+ levels with an 
optimum at 100 nM of L-T3. Although higher levels of L-T3 (1 μM) produced slight 
depression of intrasynaptosmal Ca2+ levels, picomolar levels of L-T3 were also shown to be 
able to significantly increase intrasynaptosomal Ca2+ levels in vitro. The synergistic effect of 
L-T3 and Ca2+/CaM on protein phosphorylation would likely be further amplified by the 
effect of L-T3 to increase Ca2+ levels intracellularly in the physiological situation. In 
particular, this study demonstrated that of 10 nM dose of L-T3 (brain physiological 
concentration) and a ten times higher dose of L-T3 (as observed to be the brain levels of L-T3 
in PTU-induced hypothyroid young adult rat brain synaptosomes alone or with Ca2+ did 
dramatically increased L-T3-induced total protein phosphorylation. Thus the present study 
demonstrated that Ca2+/CaM-dependent mechanisms synergistically increase the rapid 
nongenomic effect of L-T3 on synaptosomal protein phosphorylation [87]. The Ca2+/CaM-
dependent effects could be due to an activation of an unknown CaM-dependent protein 
kinase(s), deactivation of protein phosphatase(s) or a combination of effects. However, it 
proved to be highly sensitive to L-T3 activation.  
Numerous phosphoproteins are greatly influenced by PKA and PKC in a Ca2+- and/or CaM-
dependent way. Often Ca2+ also functions in combination with CaM or with 
phosphoinositides/diacylglycerol to induce additional signal transduction pathways within 
the synaptic network. Regulation of intracellular Ca2+, CaM and subsequent protein 
phosphorylation are important for brain and cognitive functions affected by various 
psychiatric disorders. Membrane depolarization-induced Ca2+-influx activates 
extracellularly regulated kinases/MAPK in a Ca2+/CaM-dependent way in PC12 cells. THs 
also promote MAPK-mediated serine phosphorylation of the nuclear TH receptor β-1 
isoform nongenomically in 293T cells. Ca2+ and CaM also differentially regulate of TH-
induced neuronal protein phosphorylation [12,87]. 
5.4.1.1.2. L-T3-induced stimulation of phosphorylation of 63- and 53 kD proteins was 
regulated by Ca2+ and calmodulin  
After getting an idea of L-T3-induced total protein phosphorylation within neuronal 
membrane it was an obvious interest to look for specific proteins phosphorylated under the 
influence of L-T3. In vitro addition of L-T3 (10 nM, brain physiologic concentrations of L-T3) 
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demonstrated differential regulation of phosphorylation status of five different 
synaptosomal proteins (63-, 53-, 38-, 23-, and 16 kD) in both a Ca2+/CaM-dependent and -
independent manner in mature rat brain cortical synaptosomes. L-T3 increased the level of 
phosphorylation of all these five proteins. Ca2+/CaM further stimulated phosphorylation of 
63- and 53 kD proteins by L-T3, which were inhibited both specifically by EGTA (Ca2+- 
chelator) or KN62 (Ca2+/CaM kinase-II [CaMK-II] inhibitor), suggesting the role of CaMK-II. 
However, presence of Ca2+ significantly decreased L-T3-induced phosphorylation of 63-, 53 
kD proteins (Figure 10). 
       
Figure 10. A. L-T3-stimulated phosphorylation of 63- and 53 kDa proteins are regulated by Ca2+/CaM-
dependent protein kinase II. (a) Representative autoradiogram of the 63- and 53 KD proteins followed 
by various treatment conditions as described. (b) Corresponding protein bands from silver stained gel 
used for normalization of the data and demonstrates comparable equal amounts of sample loading. B. 
The quantification of the L-T3 (10 nM)-induced phosphorylation presented as a graph of ratio of the 
band densities of the phosphorylated proteins in the autoradiogram (a) and the corresponding protein 
in the silver stained gel (b) at different treatment conditions as indicated. * represents the level of 
significance of P<0.05 compared to the corresponding basal level (control). The data presented are 
normalized results (mean ± S.E.M.) for an indicated protein band (Ref. Sarkar 2008 Life Sciences 82: 920-
927 acknowledged [12]).  
5.4.1.1.3. Inert action of Ca2+ and calmodulin on the independent effect of L-T3 on the 
phosphorylation of 38- and 23 kD proteins  
L-T3 also increased the phosphorylation of 23- and 38 kD proteins. The effect was 
independent of EGTA or KN62. L-T3 only slightly enhanced the phosphorylation of the 38 
kD protein (p<0.05, F = 3.74) by ~1.2-fold in the presence of Ca2+/CaM compared to Ca2+/CaM 
control group. Although addition of Ca2+ decreased the level of L-T3-induced 
phosphorylation of 38 kD protein (P = non-significant), it was significantly increased 
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(P<0.05) in the presence of CaM compared to Ca2+ + L-T3 treatment and only L-T3 effect. 
However, the presence of Ca2+ or the Ca2+/CaM did not further affect the phosphorylation 
status of the 38 kD protein. This further suggested no involvement of Ca2+/CaM-dependent 
pathways mediated through CaMK-II.  
The study also described the phosphorylation status of a 23 kD protein. Phosphorylation 
level of 23 kD protein was highest among all the proteins. L-T3 significantly increased the 
phosphorylation level of 23 kD by ~2.2-fold compared to the basal level. Especially of 
interest, EGTA or KN62 did not show any more or less influence on the L-T3-induced 
increase in the phosphorylation status of the 23 kD protein suggesting lack of significant 
regulation by CaMK-II (Figure 11).  
 
 
Figure 11. A. Ca2+/CaM do not modulate L-T3-stimulated phosphorylation of 23- and 38 kD proteins. 
(a) A representative autoradiogram of the 23- and 38 kD protein separated by SDS-PAGE showing 
independent stimulatory action of L-T3 upon the phosphorylation of the 23- and 38 kD proteins. B. The 
quantification of the L-T3-induced phosphorylation presented as a graph of ratio of the band densities 
of the phosphorylated proteins in the autoradiogram (a) and the corresponding protein in the silver 
stained gel (b) at different treatment conditions as indicated. The data presented are normalized results 
(mean ± S.E.M.) for an indicated protein band. * Indicates levels of significance P<0.05 (Ref. Sarkar 2008 
Life Sciences 82: 920-927 acknowledged [12]).  
5.4.1.1.4. Calmodulin dephosphorylated 16 kD protein following L-T3-induction 
In vitro addition of L-T3 (10 nM) significantly increased the level of phosphorylation of 16 
kD protein by ~8-fold. The L-T3-induced phosphorylation of 16 kD protein was not further 
activated in the presence of Ca2+. Surprisingly, L-T3-induced phosphorylation of 16 kD 
protein was not augmented further with Ca2+ or Ca2+/CaM; instead, the presence of CaM 
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abolished the L-T3-induced phosphorylation. EGTA or KN62 could not restore the effect of 
CaM-induced dephosphorylation of this protein (Figure 12).   
Immunoblotting experiment with anti-phosphoserine antibodies also showed significant 
enhancement of seryl residue phosphorylation of this protein by Ca2+/CaM (Figure 13). 
Abolition of this effect by EGTA and KN-62 further suggested an important role of CaMK-II. 
This study identified the role of Ca2+/CaM in the regulation of L-T3-induced protein 
phosphorylation and supported a unique nongenomic mechanism of second messenger-
mediated regulation of protein phosphorylation by TH in mature rat brain. 
 
 
Figure 12. A. Phosphorylation of 16 kD protein by L-T3 was conquered by the dephosphorylation 
activity of CaM. (a) A representative autoradiogram of the 16 kD protein separated by SDS-PAGE is 
showing independent stimulatory action of L-T3 upon the phosphorylation of the 16 kD protein. (b). 
Corresponding protein bands of silver stained gel. B. The quantification of the L-T3 (10 nM)-induced 
phosphorylation and its dephosphorylation by CaM are presented as a graph of ratio of the band 
densities of the phosphorylated proteins in the autoradiogram (a) and the corresponding protein in the 
silver stained gel (b) at different treatment conditions as indicated. The data presented are normalized 
results (mean ± S.E.M.) for an indicated protein band. * Indicates levels of significance P<0.05, compared 
to the basal level (control group) (Ref. Sarkar 2008 Life Sciences 82: 920-927 acknowledged [12]). 
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Figure 13. L-T3 induced phosphorylation of the 53 kD protein is regulated by Ca2+/calmodulin protein 
kinase II: Serine residue phosphorylation. (A) Phosphorylation status of the 53 kD protein 
immunoblotted with anti-phosphoserine (PS) antibody. (B) Corresponding protein band of silver 
stained gel. (C) Graphical representation of the levels of phosphorylation of the 53 kD protein at various 
treatment conditions. The data presented are normalized results (mean ± S.E.M.) for an indicated 
protein band. * Indicates levels of significance P<0.05, compared to the basal level (control group).   
5.4.1.2. Role of cAMP on synaptosomal protein phosphorylation, in vitro  
After searching for whether Ca2+ plays a major role as second messenger following L-T3 
induced protein phosphorylation, our next step was to examine for the role of cyclic AMP 
(cAMP) as another second messenger upon L-T3-induction, in vitro, to explore furthermore 
the nongenomic mechanism of TH. To search for any role of cAMP-dependent protein 
kinase (PKA) the effects of cAMP and H7 (a specific blocker of PKA) were studied. In vitro 
addition of H7 significantly diminished the effect of L-T3-induced increase in serine 
phosphorylation of two closely associated proteins with 51- and 53 kD by ~14-fold and ~11-
fold respectively (Figure 14). This suggested prevalence of a PKA-mediated mechanism in 
L-T3-induced synaptosomal protein phosphorylation. To test further whether THs exert 
adrenergic-like actions by binding to or modulating adrenergic receptor activities another 
study was performed to test this hypothesis. The idea of formation of thyronamines and its 
possible binding to the ADR is considered here. Effect of clonidine was studied on the L-T3-
induced protein phosphorylation and on the L-T3-binding to the synaptosomal membrane 
receptors. Scatchard plot analysis revealed clonidine and yohimbine (2-ADR antagonist) 
could not alter specific L-T3 binding at the high affinity L-T3 synaptosomal membrane 
binding sites. L-T3 induced phosphorylation of this 51-/53 kD protein was blocked by H7, a 
PKA inhibitor. Activation of 2-ADR by clonidine normally decreases the levels of cAMP via 
inhibiting adenylate cyclase activity. Possibly in the absence of adequate cAMP levels 
during clonidine treatment, the phosphorylation status of the 51-/53 kD protein remained 
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unchanged. This suggests L-T3-membrane interaction was independent of the activation of 
the 2-ADR system. Overall these data implicate that PKA and CaMK-II both contribute for 
L-T3 regulated protein phosphorylation in adult mammalian brain and reveals a 
nongenomic mechanistic pathway in relation to higher mental functions. 
 
 
Figure 14. L-T3 induced phosphorylation of the 51-/53- kD proteins are abolished by Protein Kinase A 
Inhibitor (H7). (A) One representative phosphorylation status of the 51-/53-kD protein immunoblotted 
with anti-phosphoserine (PS) antibodies. (B) Corresponding protein band of silver stained gel. (C) 
Graphical representation of the levels of phosphorylation of the 51-/53-kD protein at various treatment 
conditions. dbcAMP is dibutyryl cyclic AMP. The data presented are normalized results (mean ± 
S.E.M.) for an indicated protein band. * Indicates levels of significance p<0.05, compared to the basal 
level (control group). 
6. Conclusion  
In conclusion the recent evidence-based information regarding the nongenomic mechanism 
of action of THs are opening new signal transduction clues to be studied and to reveal the 
underlying mechanism in mature mammalian brain. The results of the study conducted will 
advance our knowledge of the fundamental molecular mechanism of TH action in mature 
CNS, likely in future will lead to more rational and effective approach to the development of 
novel therapeutic agents, and thus will shed insights on to the neuropshychological 
manifestations of adult on-set thyroid disorders in humans, particularly in relation to higher 
mental functions.  
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7. Future research direction 
Recent information regarding nongenomic mechanism of thyroid hormone action in various 
tissue types including mammalian CNS is interesting. These studies are diligently engaged 
in decoding the molecular consequences of thyroid hormone action from the specific gene 
expression to the nongenomic rapid actions of the hormone. Open-minded investigators are 
desperately searching for the truth and the relationship of thyroid hormone action 
explicated through its classical well-known doctrine which is mediated via activation of 
specific nuclear receptors to the newly emerging idea of rapid nongenomic actions of the 
hormone and an association to enlighten the both. In particular, adult mammalian brain are 
of best curiosity since clinical observations of numerous thyroid dysfunction related 
neuropsychological disorders produced during mature conditions in humans can be 
corrected with the adjustment of the thyroid hormone levels. However the mechanism of 
action is lacking. Nongenomic rapid events mediated by thyroid hormones could have 
connection to the long-term genomic actions. Deciphering the nongenomic molecular 
mechanism of action of thyroid hormones has future prospects to study its importance 
regulating higher mental functions in humans. This fundamental knowledge could be the 
basis to find novel strategies to treat adult-onset thyroid dysfunctions including 
neuropsychological diseases many of which are precisely controlled by demarcated cellular 
fine-tuning of the protein phosphorylation mechanisms related to neuronal signal 
transmission. 
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